Graph Neural Networks Outperform Traditional Models for Predicting Blood Pressure Peptides
A graph convolutional network using molecular graph representations outperformed traditional machine learning for predicting ACE-inhibitory peptides of varying lengths.
Quick Facts
What This Study Found
A graph convolutional network using molecular graph representations outperformed traditional machine learning models for predicting ACE-inhibitory peptides of varying lengths.
Key Numbers
Peptides containing 2-10 amino acids were represented as molecular graphs. The GCN model was compared against random forest, support vector machine, and other ML models.
How They Did This
Computational study comparing graph convolutional network models to traditional ML models for predicting ACE-inhibitory activity of peptides with 2-10 amino acids.
Why This Research Matters
ACE inhibitors are among the most prescribed blood pressure drugs. Finding new ACE-inhibiting peptides from natural sources could provide alternative or complementary treatments.
The Bigger Picture
ACE inhibitors are among the most prescribed drugs. Finding new ACE-inhibiting peptides from food and natural sources could provide alternative blood pressure treatments with fewer side effects.
What This Study Doesn't Tell Us
Computational predictions need experimental validation. The model's accuracy may vary for peptides outside the training data range.
Questions This Raises
- ?Can the GCN model be validated with experimental testing of predicted peptides?
- ?Does this approach work for other bioactive peptide targets?
Trust & Context
- Key Stat:
- GCN outperformed all others Graph convolutional networks using molecular graph representations predicted ACE-inhibitory activity better than all traditional ML approaches
- Evidence Grade:
- Rated preliminary: computational method comparison study. Predicted peptides need experimental validation.
- Study Age:
- Published in 2024. Graph neural networks are a cutting-edge approach in computational drug discovery.
- Original Title:
- Predicting variable-length ACE inhibitory peptides based on graph convolutional network.
- Published In:
- International journal of biological macromolecules, 282(Pt 5), 137060 (2024)
- Authors:
- Rong, Yating, Feng, Baolong, Cai, Xiaoshuang, Song, Hongjie, Wang, Lili, Wang, Yehui, Yan, Xinxu, Sun, Yulin, Zhao, Jinyong, Li, Ping, Yang, Huihui, Wang, Yutang, Wang, Fengzhong
- Database ID:
- RPEP-09169
Evidence Hierarchy
Frequently Asked Questions
What are ACE-inhibitory peptides?
Natural peptides (often from food proteins) that can lower blood pressure by inhibiting the same enzyme targeted by drugs like lisinopril and ramipril.
Why use graph neural networks for peptides?
Traditional methods struggle to capture the complex 3D relationships in peptide molecules. Graph networks represent atoms and bonds as connected networks, preserving structural information.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09169APA
Rong, Yating; Feng, Baolong; Cai, Xiaoshuang; Song, Hongjie; Wang, Lili; Wang, Yehui; Yan, Xinxu; Sun, Yulin; Zhao, Jinyong; Li, Ping; Yang, Huihui; Wang, Yutang; Wang, Fengzhong. (2024). Predicting variable-length ACE inhibitory peptides based on graph convolutional network.. International journal of biological macromolecules, 282(Pt 5), 137060. https://doi.org/10.1016/j.ijbiomac.2024.137060
MLA
Rong, Yating, et al. "Predicting variable-length ACE inhibitory peptides based on graph convolutional network.." International journal of biological macromolecules, 2024. https://doi.org/10.1016/j.ijbiomac.2024.137060
RethinkPeptides
RethinkPeptides Research Database. "Predicting variable-length ACE inhibitory peptides based on ..." RPEP-09169. Retrieved from https://rethinkpeptides.com/research/rong-2024-predicting-variablelength-ace-inhibitory
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.